Bella Smith created a new blog entry
on July 24 at 02:59 AM public
New Alzheimer's Disease Drug Receives Full FDA Approval
On January 6, 2023, lecanemab (trade name Leqembi), an Alzheimer's disease drug developed by Eisai and Biogen, received conditional approval from the FDA. The results of its Phase 3 clinical...